why choose us

First received: April 06, 2025

Clinical Trial: Efficacy & Safety of Minoxidil SL Tablets in Men With AGA

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Androgenetic Alopecia
Male Pattern Baldness

Study Type: INTERVENTIONAL


Official Title: Phase 3, Multicentre, Randomised, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Minoxidil Sublingual (SL) Tablet (2.5 mg) Twice Daily (BID) in the Treatment of Male A

Brief Summary: This is a phase 3, multicentre, randomised, double-blinded, placebo-controlled study examining the safety and efficacy of 2.5 mg sublingual (SL) minoxidil tablets taken twice daily in the treatment of androgenetic alopecia (AGA) in men. The duration of study participation is 32 weeks including screening and safety follow up.The primary efficacy objective is to determine whether treatment with 2.5 mg SL tablets twice daily increases the number of hairs in men with AGA over 24 weeks. The primary safety objective is…

Read more